Results 351 to 360 of about 3,369,116 (395)
Some of the next articles are maybe not open access.
Investigative Radiology, 1985
Cardiac transplantation is now accepted as the therapy of choice for irreversible, advanced heart failure. Improving results have been observed since 1980. This is the consequence of better defined criteria for selection of recipients, refined use of antilymphocyte serum, improved myocardial preservation methods, and the introduction of cyclosporine ...
J P, Goldstein, A S, Wechsler
openaire +4 more sources
Cardiac transplantation is now accepted as the therapy of choice for irreversible, advanced heart failure. Improving results have been observed since 1980. This is the consequence of better defined criteria for selection of recipients, refined use of antilymphocyte serum, improved myocardial preservation methods, and the introduction of cyclosporine ...
J P, Goldstein, A S, Wechsler
openaire +4 more sources
Diseases of the Chest, 1965
The performance of the heart has been examined after cardiac homo- and autotransplantation. In the early postoperative period, measurements of cardiovascular responses reaffirm the good clinical condition of these preparations. In the late postoperative period the evidence suggests that both sympathetic and parasympathetic reinnervation occur and that ...
Eugene Dong +3 more
openaire +3 more sources
The performance of the heart has been examined after cardiac homo- and autotransplantation. In the early postoperative period, measurements of cardiovascular responses reaffirm the good clinical condition of these preparations. In the late postoperative period the evidence suggests that both sympathetic and parasympathetic reinnervation occur and that ...
Eugene Dong +3 more
openaire +3 more sources
Current Opinion in Cardiology, 1995
Increased experience and knowledge in the field of heart transplantation has resulted in continued expansion of this clinical activity. The same experience has served to identify many problems and provided some answers which are in many instances incomplete. The outstanding problems in heart transplantation are firstly the availability of donor organs,
J R, Pepper, A, Khagani, M, Yacoub
openaire +4 more sources
Increased experience and knowledge in the field of heart transplantation has resulted in continued expansion of this clinical activity. The same experience has served to identify many problems and provided some answers which are in many instances incomplete. The outstanding problems in heart transplantation are firstly the availability of donor organs,
J R, Pepper, A, Khagani, M, Yacoub
openaire +4 more sources
Chimerism of the Transplanted Heart
New England Journal of Medicine, 2002Cases in which a male patient receives a heart from a female donor provide an unusual opportunity to test whether primitive cells translocate from the recipient to the graft and whether cells with the phenotypic characteristics of those of the recipient ultimately reside in the donor heart.
Quaini, F. +8 more
openaire +5 more sources
Journal of Intensive Care Medicine, 2004
Although the number of available donor hearts severely limits the epidemiologic impact of heart transplantation on patients with heart failure, patients with end-stage heart failure unresponsive to medical management currently have no other viable alternatives.
Robert S, Poston, Bartley P, Griffith
openaire +2 more sources
Although the number of available donor hearts severely limits the epidemiologic impact of heart transplantation on patients with heart failure, patients with end-stage heart failure unresponsive to medical management currently have no other viable alternatives.
Robert S, Poston, Bartley P, Griffith
openaire +2 more sources
Critical Care Nursing Clinics of North America, 2011
Cardiac transplantation remains a life-prolonging process. Survival after heart transplantation has improved despite a sicker incoming patient population. The field of heart transplantation is constantly evolving. Advances in organ preservation, immune monitoring, and improved immunosuppressive regimens will continue to develop over time. The impact of
Jeannine V, DiNella, Jennifer, Bowman
openaire +2 more sources
Cardiac transplantation remains a life-prolonging process. Survival after heart transplantation has improved despite a sicker incoming patient population. The field of heart transplantation is constantly evolving. Advances in organ preservation, immune monitoring, and improved immunosuppressive regimens will continue to develop over time. The impact of
Jeannine V, DiNella, Jennifer, Bowman
openaire +2 more sources
Heart and Heart-Lung Transplantation
Nursing Clinics of North America, 1989The fields of heart and combined heart-lung transplantation continue to evolve, allowing treatment of more individuals with end-stage heart and lung disease. The postoperative course and rehabilitation phase may be arduous, emphasizing the importance of selecting candidates who meet specific medical and psychosocial criteria.
openaire +4 more sources
Current Opinion in Organ Transplantation, 2010
This paper briefly and subjectively reviews a number of the modest or tentative, but noteworthy, advances in heart transplantation that have been made during the past 18 months or so.The advances reviewed concern the selection of recipients, the management of the heart transplantation waiting list, the management of donors, post-heart transplant ...
Maria G, Crespo-Leiro +3 more
openaire +2 more sources
This paper briefly and subjectively reviews a number of the modest or tentative, but noteworthy, advances in heart transplantation that have been made during the past 18 months or so.The advances reviewed concern the selection of recipients, the management of the heart transplantation waiting list, the management of donors, post-heart transplant ...
Maria G, Crespo-Leiro +3 more
openaire +2 more sources
2019
Heart transplantation remains the treatment of choice for end-stage heart failure refractory to conventional treatment. Long-term outcome is excellent, and median survival currently exceeds 13 years. The main causes of death late after transplantation are cardiac allograft vasculopathy and cancer.
Finn Gustafsson, Kasper Rossing
openaire +1 more source
Heart transplantation remains the treatment of choice for end-stage heart failure refractory to conventional treatment. Long-term outcome is excellent, and median survival currently exceeds 13 years. The main causes of death late after transplantation are cardiac allograft vasculopathy and cancer.
Finn Gustafsson, Kasper Rossing
openaire +1 more source
Transplantation, 2016
Background Frailty is a clinically recognized syndrome of decreased physiological reserve. The heightened state of vulnerability in these patients confers a greater risk of adverse outcomes after even minor stressors. Our aim was to assess the prevalence
S. Jha +11 more
semanticscholar +1 more source
Background Frailty is a clinically recognized syndrome of decreased physiological reserve. The heightened state of vulnerability in these patients confers a greater risk of adverse outcomes after even minor stressors. Our aim was to assess the prevalence
S. Jha +11 more
semanticscholar +1 more source